A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation (Reshape-HF2)
Randomised Investigation of the MitraClip Device in Heart Failure: 2nd Trial in Patients With Clinically Significant Functional Mitral Regurgitation
Sponsor: University Medical Center Goettingen
A NA clinical study on Mitral Valve Insufficiency, this trial is completed. The trial is conducted by University Medical Center Goettingen and has accumulated 14 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Oct 2024 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Oct 2024 [monthly]
Completed NA
-
Aug 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2024 — Aug 2024 [monthly]
Completed NA
▶ Show 9 earlier versions
-
May 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2024 — May 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Feb 2024 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Medical Center Goettingen
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Athens, Greece , Badalona, Spain , Berlin, Germany , Brescia, Italy , Copenhagen, Denmark , Düsseldorf, Germany , Edinburgh, United Kingdom , Essen, Germany , Genthin, Germany , Glasgow, United Kingdom and 23 more locations